Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate CancerRichard Gagnon, Steven Yip, Daniel Yick Chin Heng et al.|Clinical Genitourinary Cancer|2024Cited by 6
Prognostic biomarkers and clinical outcomes in neuroendocrine prostate cancer (NEPC).Richard Gagnon, Steven Yip, Ealia Khosh Kish et al.|Journal of Clinical Oncology|2023Cited by 3
Analysis of the role of PI3K-AKT and DNA damage repair (DDR) genomic biomarkers as predictors of clinical outcomes in nonmetastatic castration-resistant prostate cancer (nmCRPC).Richard Gagnon, Steven Yip, Soufiane El Hallani et al.|Journal of Clinical Oncology|2022Cited by 0